newsfilter
← Latest News
PR Newswire·

Curis to be Added to the Nasdaq Biotechnology Index and the iShares Biotechnology ETF

LEXINGTON, Mass., Dec. 15, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has been selected for addition to the Nasdaq Bio